Literature DB >> 4953570

Thiotepa in the treatment of advanced breast cancer.

A R Lyons, G A Edelstyn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 4953570      PMCID: PMC2071340          DOI: 10.1038/bjc.1965.58

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  CYCLOPHOSPHAMIDE IN TREATMENT OF LOCALLY RECURRENT BREAST CANCER.

Authors:  G A EDELSTYN
Journal:  Lancet       Date:  1965-01-30       Impact factor: 79.321

2.  Thiotepa in treatment of advanced breast cancer.

Authors:  A LYONS; G EDELSTYN
Journal:  Br Med J       Date:  1962-11-17

3.  Toxic marrow failure after treatment of carcinoma with cytotoxic drugs.

Authors:  I C CREE
Journal:  Br Med J       Date:  1960-11-19

4.  Breast cancer; a new approach to therapy.

Authors:  G W WATSON; R L TURNER
Journal:  Br Med J       Date:  1959-05-23

5.  Toxic marrow failure treated by a homograft of foetal haemopoietic tissue.

Authors:  J B BRIDGES; J M BRIDGES; G J EDELSTYN; A R LYONS; M G NELSON
Journal:  Lancet       Date:  1960-03-19       Impact factor: 79.321

  5 in total
  2 in total

1.  [Cytostatic therapy in breast carcinoma].

Authors:  K Karrer
Journal:  Langenbecks Arch Chir       Date:  1970-12

2.  Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study).

Authors:  Ga-Young Song; Sung-Hoon Jung; Jin Seok Kim; Hyeon Seok Eom; Joon Ho Moon; Ho-Young Yhim; Kihyun Kim; Chang-Ki Min; Je-Jung Lee
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.